Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality

BiotechReality - Information Intelligence System for Biopharma

  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#FDA #Eli Lilly and Company #Johnson&Johnson #Phase 3 Trial #FDA Approval #Clinical Data #Hoffmann-La Roche #Pfizer
Virology News

SARS-CoV-2 which causes COVID-19 is widespread in wild animals

  • By Journal Updates
  • 31 July 2024
covid 19 mutation

The results underline the necessity for widespread surveillance as well as the discovery of new SARS-CoV-2 mutations in animals.

Tagged COVID19, SARS-CoV-2
Neuroscience Research

Developing connections between neurons to maintain brain health

  • By Editor's Desk
  • 29 July 2024
neuron connections

Alzheimer’s disease, frontotemporal dementia, and Parkinson’s disease are among the neurodegenerative diseases that are characterized by the buildup of abnormal proteins.

Tagged Brain Health, Neurons
Biotechnology Laboratory Info

Autoclave Sterilization – Principle, Procedure and Types

  • By Achuth B S
  • 27 July 2024
Autoclave image

   Table of contents  Principle Components Procedure Types Autoclave sterilization is a common sterilization method used in biological laboratories. It has a principle of physical/moist [Read More…]

Neuroscience Research

Research identified brain circuits for placebo effect pain relief

  • By Editor's Desk
  • 26 July 2024
covid brain

The researchers then demonstrated that specific neurons and synapses along this pathway are highly activated when mice expect and experience pain relief, even in the absence of medication.

Tagged Brain, Placebo Effect
Genetics Artificial Intelligence Technology

Genetic diagnostics identifies 34 new genetic diseases

  • By Editor's Desk
  • 24 July 2024
genetic diagnostics

For the best possible care, ultra-rare illnesses need both sophisticated genetic tests and diverse clinical competence.

Tagged Artificial Intelligence, Genetic Diagnostics, Genetic Diseases
Research News

Latest research finds mechanism for skeletal muscle regeneration

  • By Editor's Desk
  • 23 July 2024
skeletal muscle

During the process of embryonic development, hundreds of specialized cells known as myoblasts fuse to become skeletal muscles.

Tagged Regeneration, Skeletal Muscle
Healthcare & Pharmaceuticals News Research

Research promises a universal flu vaccine

  • By Editor's Desk
  • 22 July 2024
vaccine vial image

Six out of eleven nonhuman primates who received an inoculation against the 1918 flu virus, which was prevalent a century ago, reportedly withstood exposure to H5N1, one of the worst viruses now circulating in the globe. On the other hand, six uninfected monkeys in the control group that were infected with the H5N1 virus died from the illness.

Tagged Universal Flu Vaccine
Microscopy News Research

Innovative microscopy traces amyloid beta’s underlying structure for neurodegenerative disease research

  • By Journal Updates
  • 21 July 2024
amyloid beta protein structure

Researchers can now discern orientation and other minute characteristics in the nanostructures of biological systems that were previously unseen thanks to a new imaging technology developed by the Lew lab.

Tagged Amyloid Beta Structure, Protein Structure
Research

Discovery of bacteria that can destroy Forever Chemicals

  • By Editor's Desk
  • 20 July 2024
antibiotic resistant bacteria

Per- and polyfluoroalkyl substances, or PFAS, are another name for forever chemicals. These compounds persist in the environment because of their strong carbon-fluorine chemical interactions.

Tagged Bacteria, Forever Chemicals
Biotechnology News Toxicology

CRISPR technology paves the way for a new antidote for Cobra bites

  • By Editor's Desk
  • 19 July 2024
Cobra Snake Image

Every year, hundreds of individuals are killed by cobra venom, and an estimated 100,000 more suffer severe injuries from necrosis, which is the loss of bodily tissue and cells and can result in amputation.

Tagged Cobra Venom, CRISPR

Posts navigation

← Older Posts
→ Newer Posts
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRO
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

EBGLYSS Durable Efficacy: Lilly Reports Landmark 4-Year Results for Atopic Dermatitis
Clinical Trials Clinical Data Healthcare & Pharmaceuticals News

EBGLYSS Durable Efficacy: Lilly Reports Landmark 4-Year Results for Atopic Dermatitis

27 March 202628 March 2026
Clinical Trials & Data Desk
Pfizer and Valneva Announce Strong Efficacy for Lyme Disease Vaccine Candidate
Clinical Trials Clinical Data News Vaccines

Pfizer and Valneva Announce Strong Efficacy for Lyme Disease Vaccine Candidate

26 March 202626 March 2026
Clinical Trials & Data Desk
Novo Nordisk’s UBT251 Triple Agonist Achieves Landmark 2.16% HbA1c Reduction in Type 2 Diabetes Phase 2 Trial
Clinical Trials Clinical Data Diabetes News

Novo Nordisk’s UBT251 Triple Agonist Achieves Landmark 2.16% HbA1c Reduction in Type 2 Diabetes Phase 2 Trial

25 March 202625 March 2026
Clinical Trials & Data Desk
Novartis Immunology Data at AAD 2026: Rhapsido and Cosentyx Results
Autoimmune Diseases Clinical Data Clinical Trials Healthcare & Pharmaceuticals News

Novartis Immunology Data at AAD 2026: Rhapsido and Cosentyx Results

24 March 202624 March 2026
Clinical Trials & Data Desk
GSK Secures Japan Orphan Drug Designation for Risvutatug Rezetecan in Small-Cell Lung Cancer
News Clinical Data Oncology Regulatory

GSK Secures Japan Orphan Drug Designation for Risvutatug Rezetecan in Small-Cell Lung Cancer

23 March 202623 March 2026
Clinical Trials & Data Desk
Pfizer’s Talzenna + Xtandi Delivers Proven rPFS Breakthrough in HRR-Mutated mCSPC
Clinical Trials Healthcare & Pharmaceuticals News

Pfizer’s Talzenna + Xtandi Delivers Proven rPFS Breakthrough in HRR-Mutated mCSPC

20 March 202620 March 2026
Clinical Trials & Data Desk
Advertisement
BiotechReality JobFinder

  • Medical Device Associate Consultant
    26 March 2026
  • Manufacturing Quality Assurance Engineer
    26 March 2026
  • Product Manager – Immunoassay
    26 March 2026
  • Quality Specialist
    24 March 2026
  • Chemist – Laboratory
    19 March 2026

BiotechReality Shots Weekly News letter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter
We use cookies to improve your browsing experience, deliver personalized content and ads, and analyze our traffic. By clicking “Accept All”, you consent to our use of cookies.